IONIS-JBI2-2.5Rx

J&J goes back to Ionis for its second experimental pill for a GI autoimmune disease
Endpoints
Thu, 11/16/17 - 11:08 am
JNJ
Ionis Pharmaceuticals
autoimmune disease
IONIS-JBI2-2.5Rx
antisense